148 related articles for article (PubMed ID: 27584056)
1. A PPARδ-selective antagonist ameliorates IMQ-induced psoriasis-like inflammation in mice.
Wang X; Hao Y; Wang X; Wang L; Chen Y; Sun J; Hu J
Int Immunopharmacol; 2016 Nov; 40():73-78. PubMed ID: 27584056
[TBL] [Abstract][Full Text] [Related]
2. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
[TBL] [Abstract][Full Text] [Related]
3. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
4. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N
Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402
[TBL] [Abstract][Full Text] [Related]
5. Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice.
Jeon YJ; Sah SK; Yang HS; Lee JH; Shin J; Kim TY
Exp Mol Med; 2017 Jun; 49(6):e349. PubMed ID: 28665921
[TBL] [Abstract][Full Text] [Related]
6. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
7. BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis.
Irrera N; Vaccaro M; Bitto A; Pallio G; Pizzino G; Lentini M; Arcoraci V; Minutoli L; Scuruchi M; Cutroneo G; Anastasi GP; Ettari R; Squadrito F; Altavilla D
Clin Sci (Lond); 2017 Mar; 131(6):487-498. PubMed ID: 28096316
[TBL] [Abstract][Full Text] [Related]
8. Involvement of high mobility group box-1 in imiquimod-induced psoriasis-like mice model.
Chen T; Fu LX; Guo ZP; Yin B; Cao N; Qin S
J Dermatol; 2017 May; 44(5):573-581. PubMed ID: 27943400
[TBL] [Abstract][Full Text] [Related]
9. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
[TBL] [Abstract][Full Text] [Related]
10. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
11. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
[TBL] [Abstract][Full Text] [Related]
12. Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion.
Zhao J; Di T; Wang Y; Wang Y; Liu X; Liang D; Li P
Eur J Pharmacol; 2016 Feb; 772():131-43. PubMed ID: 26738780
[TBL] [Abstract][Full Text] [Related]
13. Periplogenin induces necroptotic cell death through oxidative stress in HaCaT cells and ameliorates skin lesions in the TPA- and IMQ-induced psoriasis-like mouse models.
Zhang WJ; Song ZB; Bao YL; Li WL; Yang XG; Wang Q; Yu CL; Sun LG; Huang YX; Li YX
Biochem Pharmacol; 2016 Apr; 105():66-79. PubMed ID: 26850986
[TBL] [Abstract][Full Text] [Related]
14. Ascorbic acid derivative DDH-1 ameliorates psoriasis-like skin lesions in mice by suppressing inflammatory cytokine expression.
Kitahata K; Matsuo K; Hara Y; Naganuma T; Oiso N; Kawada A; Nakayama T
J Pharmacol Sci; 2018 Dec; 138(4):284-288. PubMed ID: 30503675
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
[TBL] [Abstract][Full Text] [Related]
16. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.
Stjernholm T; Ommen P; Langkilde A; Johansen C; Iversen L; Rosada C; Stenderup K
Exp Dermatol; 2017 Apr; 26(4):338-345. PubMed ID: 27488462
[TBL] [Abstract][Full Text] [Related]
17. Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice.
Bai S; Zhang Z; Hou S; Liu X
Mol Med Rep; 2016 Jul; 14(1):671-80. PubMed ID: 27221314
[TBL] [Abstract][Full Text] [Related]
18. IMQ Induced K14-VEGF Mouse: A Stable and Long-Term Mouse Model of Psoriasis-Like Inflammation.
Wang X; Sun J; Hu J
PLoS One; 2015; 10(12):e0145498. PubMed ID: 26691862
[TBL] [Abstract][Full Text] [Related]
19. Local production of prolactin in lesions may play a pathogenic role in psoriatic patients and imiquimod-induced psoriasis-like mouse model.
Yang H; Li X; Xue F; Xia Q; Zhao X; Wang D; Chen L; Cao H; Xu H; Shen X; Yuan W; Zhao X; Shi R; Zheng J
Exp Dermatol; 2018 Nov; 27(11):1245-1253. PubMed ID: 30120801
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod Increases Cutaneous VEGF Expression in Imiquimod-induced Psoriatic Mouse Model.
Wu HH; Xie WL; Zhao YK; Liu JH; Luo DQ
Curr Vasc Pharmacol; 2016; 14(3):275-9. PubMed ID: 26733387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
